Recorded exposure to different corticosteroids and univariate association with cataract
| Exposure to: | Cases (n = 15479) | Controls (n = 15479) | Odds ratio (95% CI) |
|---|---|---|---|
| *Rectal, vaginal, dental, intra-articular, and intracutaneous. | |||
| Inhaled corticosteroid | 1766 (11.4%) | 1180 (7.6%) | 1.58 (1.46 to 1.71) |
| Ocular corticosteroid | 1442 (9.3%) | 725 (4.7%) | 2.12 (1.93 to 2.33) |
| Systemic steroids, oral | 2052 (13.3%) | 1389 (9.0%) | 1.59 (1.47 to 1.71) |
| Systemic steroids, parenteral | 450 (2.9%) | 298 (1.9%) | 1.56 (1.34 to1.82) |
| Topical steroids, skin | 5729 (37.0%) | 4585 (29.6%) | 1.43 (1.36 to 1.50) |
| Topical steroids, nasal | 1224 (7.9%) | 949 (6.1%) | 1.33 (1.21 to 1.45) |
| Topical steroids, ear | 1020 (6.6%) | 794 (5.1%) | 1.31 (1.19 to 1.45) |
| Topical steroids, other* | 1587 (10.2%) | 1219 (7.9%) | 1.35 (1.25 to 1.46) |